advisorsecurities master

RNAZTransCode Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
21060
Ticker
RNAZ
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-07-09
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
RNAZ

Detail

Enriched 2026-08-14 20:47

Market cap
$3,567,080.97
Shares outstanding (class)
1,058,481
Shares outstanding (weighted)
1,058,481
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
12
Location
BOSTON, MA
Description

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data